(Reuters) – Advisors to the European Medicines Agency (EMA) on Friday backed the use of a tetravalent dengue vaccine by the German unit of Japan’s Takeda for people aged four years and above.
(Reporting by Raghav Mahobe; Editing by Maju Samuel)
(Reuters) – Advisors to the European Medicines Agency (EMA) on Friday backed the use of a tetravalent dengue vaccine by the German unit of Japan’s Takeda for people aged four years and above.
(Reporting by Raghav Mahobe; Editing by Maju Samuel)